OHSU researchers identify promising next-generation cancer

$ 8.99

4.7
(472)
In stock
Description

Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.

LGBTQ+ fertility treatment is rapidly advancing. Here's how

OHSU researchers identify promising next-generation cancer treatment

Stories OHSU News

OHSU attracts nearly $600 million in research funding — a record

New version of HIV vaccine could soon be ready for clinical trials

IJMS August-1 2023 - Browse Articles

Telehealth may improve contraception care, intimate partner violence

OHSU 2023 accomplishments: The year in review

Stories OHSU News

The future of CRISPR is now

OHSU, Intel partner on genetics

CIRM funded research

MRI innovation for the first time reveals cells' energy activity in organs and tissues

Search OHSU News

OHSU researchers identify promising next-generation cancer treatment